Skip to main content
icon for 트럼프는 다음 FDA 위원으로 누구를 발표할 것인가?

트럼프는 다음 FDA 위원으로 누구를 발표할 것인가?

icon for 트럼프는 다음 FDA 위원으로 누구를 발표할 것인가?

트럼프는 다음 FDA 위원으로 누구를 발표할 것인가?

Kyle Diamantas 59%

Stephen Hahn 25%

Grace Graham 20%

No announcement by December 31 20%

Polymarket
신규

Kyle Diamantas 59%

Stephen Hahn 25%

Grace Graham 20%

No announcement by December 31 20%

Polymarket
신규

Kyle Diamantas

$82 거래량

59%

Stephen Hahn

$70 거래량

38%

Brett Giroir

$35 거래량

16%

Grace Graham

$36 거래량

20%

Sara Brenner

$44 거래량

49%

No announcement by December 31

$35 거래량

20%

This market will resolve according to the first individual Donald Trump announces as his pick to be United States Food and Drug Administration (FDA) Commissioner. An announcement from Donald Trump or the Trump administration stating their intent to nominate a specific individual to be United States Food and Drug Administration (FDA) Commissioner will suffice to resolve this market, regardless of whether a formal nomination actually occurs. Qualifying announcements must explicitly present the relevant individual as the nominee or future nominee for FDA Commissioner. Announcements of acting or interim appointments, or announcements which merely reveal potential candidates, will not qualify. Media reports, speculation, or other unofficial information will not qualify. A formal presidential nomination of an individual to be United States Food and Drug Administration (FDA) Commissioner will also suffice to resolve this market. Formal nominations are defined as the submission of a nomination message to the U.S. Senate. If Donald Trump does not announce his pick for the next United States Food and Drug Administration (FDA) Commissioner by December 31, 2026, 11:59 PM ET, this market will resolve to “No announcement by December 31”. The resolution source for this market will be official information from Donald Trump and the Trump Administration; however, a consensus of credible reporting may also be used.

This market will resolve according to the first individual Donald Trump announces as his pick to be United States Food and Drug Administration (FDA) Commissioner.

An announcement from Donald Trump or the Trump administration stating their intent to nominate a specific individual to be United States Food and Drug Administration (FDA) Commissioner will suffice to resolve this market, regardless of whether a formal nomination actually occurs.

Qualifying announcements must explicitly present the relevant individual as the nominee or future nominee for FDA Commissioner.

Announcements of acting or interim appointments, or announcements which merely reveal potential candidates, will not qualify. Media reports, speculation, or other unofficial information will not qualify.

A formal presidential nomination of an individual to be United States Food and Drug Administration (FDA) Commissioner will also suffice to resolve this market. Formal nominations are defined as the submission of a nomination message to the U.S. Senate.

If Donald Trump does not announce his pick for the next United States Food and Drug Administration (FDA) Commissioner by December 31, 2026, 11:59 PM ET, this market will resolve to “No announcement by December 31”.

The resolution source for this market will be official information from Donald Trump and the Trump Administration; however, a consensus of credible reporting may also be used.
거래량
$265
종료일
2026.12.31
마켓 개설일
May 12, 2026, 7:59 PM ET
This market will resolve according to the first individual Donald Trump announces as his pick to be United States Food and Drug Administration (FDA) Commissioner. An announcement from Donald Trump or the Trump administration stating their intent to nominate a specific individual to be United States Food and Drug Administration (FDA) Commissioner will suffice to resolve this market, regardless of whether a formal nomination actually occurs. Qualifying announcements must explicitly present the relevant individual as the nominee or future nominee for FDA Commissioner. Announcements of acting or interim appointments, or announcements which merely reveal potential candidates, will not qualify. Media reports, speculation, or other unofficial information will not qualify. A formal presidential nomination of an individual to be United States Food and Drug Administration (FDA) Commissioner will also suffice to resolve this market. Formal nominations are defined as the submission of a nomination message to the U.S. Senate. If Donald Trump does not announce his pick for the next United States Food and Drug Administration (FDA) Commissioner by December 31, 2026, 11:59 PM ET, this market will resolve to “No announcement by December 31”. The resolution source for this market will be official information from Donald Trump and the Trump Administration; however, a consensus of credible reporting may also be used.
This market will resolve according to the first individual Donald Trump announces as his pick to be United States Food and Drug Administration (FDA) Commissioner. An announcement from Donald Trump or the Trump administration stating their intent to nominate a specific individual to be United States Food and Drug Administration (FDA) Commissioner will suffice to resolve this market, regardless of whether a formal nomination actually occurs. Qualifying announcements must explicitly present the relevant individual as the nominee or future nominee for FDA Commissioner. Announcements of acting or interim appointments, or announcements which merely reveal potential candidates, will not qualify. Media reports, speculation, or other unofficial information will not qualify. A formal presidential nomination of an individual to be United States Food and Drug Administration (FDA) Commissioner will also suffice to resolve this market. Formal nominations are defined as the submission of a nomination message to the U.S. Senate. If Donald Trump does not announce his pick for the next United States Food and Drug Administration (FDA) Commissioner by December 31, 2026, 11:59 PM ET, this market will resolve to “No announcement by December 31”. The resolution source for this market will be official information from Donald Trump and the Trump Administration; however, a consensus of credible reporting may also be used.

This market will resolve according to the first individual Donald Trump announces as his pick to be United States Food and Drug Administration (FDA) Commissioner.

An announcement from Donald Trump or the Trump administration stating their intent to nominate a specific individual to be United States Food and Drug Administration (FDA) Commissioner will suffice to resolve this market, regardless of whether a formal nomination actually occurs.

Qualifying announcements must explicitly present the relevant individual as the nominee or future nominee for FDA Commissioner.

Announcements of acting or interim appointments, or announcements which merely reveal potential candidates, will not qualify. Media reports, speculation, or other unofficial information will not qualify.

A formal presidential nomination of an individual to be United States Food and Drug Administration (FDA) Commissioner will also suffice to resolve this market. Formal nominations are defined as the submission of a nomination message to the U.S. Senate.

If Donald Trump does not announce his pick for the next United States Food and Drug Administration (FDA) Commissioner by December 31, 2026, 11:59 PM ET, this market will resolve to “No announcement by December 31”.

The resolution source for this market will be official information from Donald Trump and the Trump Administration; however, a consensus of credible reporting may also be used.
거래량
$265
종료일
2026.12.31
마켓 개설일
May 12, 2026, 7:59 PM ET
This market will resolve according to the first individual Donald Trump announces as his pick to be United States Food and Drug Administration (FDA) Commissioner. An announcement from Donald Trump or the Trump administration stating their intent to nominate a specific individual to be United States Food and Drug Administration (FDA) Commissioner will suffice to resolve this market, regardless of whether a formal nomination actually occurs. Qualifying announcements must explicitly present the relevant individual as the nominee or future nominee for FDA Commissioner. Announcements of acting or interim appointments, or announcements which merely reveal potential candidates, will not qualify. Media reports, speculation, or other unofficial information will not qualify. A formal presidential nomination of an individual to be United States Food and Drug Administration (FDA) Commissioner will also suffice to resolve this market. Formal nominations are defined as the submission of a nomination message to the U.S. Senate. If Donald Trump does not announce his pick for the next United States Food and Drug Administration (FDA) Commissioner by December 31, 2026, 11:59 PM ET, this market will resolve to “No announcement by December 31”. The resolution source for this market will be official information from Donald Trump and the Trump Administration; however, a consensus of credible reporting may also be used.

외부 링크에 주의하세요.

자주 묻는 질문

"트럼프는 다음 FDA 위원으로 누구를 발표할 것인가?"은 6개의 가능한 결과가 있는 Polymarket의 예측 마켓으로, 트레이더들이 어떤 결과가 발생할지에 따라 주식을 매수 및 매도합니다. 현재 선두 결과는 59%의 "Kyle Diamantas"이며, 이어서 49%의 "Sara Brenner"입니다. 가격은 실시간 크라우드소싱 확률을 반영합니다. 예를 들어 59¢에 거래되는 주식은 마켓이 해당 결과에 59%의 확률을 부여함을 의미합니다. 이 확률은 트레이더들이 새로운 진전과 정보에 반응함에 따라 지속적으로 변화합니다. 정확한 결과의 주식은 마켓 정산 시 각 $1에 교환 가능합니다.

"트럼프는 다음 FDA 위원으로 누구를 발표할 것인가?"은 Polymarket에서 새로 생성된 마켓입니다, May 13, 2026에 시작됨. 초기 마켓으로서 확률을 설정하고 마켓의 초기 가격 신호를 수립하는 첫 번째 트레이더 중 하나가 될 기회입니다. 이 페이지를 북마크하여 마켓이 성장함에 따라 거래량과 거래 활동을 추적할 수도 있습니다.

"트럼프는 다음 FDA 위원으로 누구를 발표할 것인가?"에서 거래하려면 이 페이지에 나열된 6개의 가용 결과를 탐색하세요. 각 결과에는 마켓의 내재 확률을 나타내는 현재 가격이 표시됩니다. 포지션을 잡으려면 가장 가능성이 높다고 생각하는 결과를 선택하고, 찬성이면 "Yes", 반대이면 "No"를 선택하고, 금액을 입력하고 "거래"를 클릭하세요. 마켓이 정산될 때 선택한 결과가 맞으면 "Yes" 주식은 각 $1을 지급합니다. 틀리면 $0을 지급합니다. 수익을 확정하거나 손실을 줄이고 싶다면 정산 전 언제든지 주식을 매도할 수 있습니다.

"트럼프는 다음 FDA 위원으로 누구를 발표할 것인가?"의 현재 유력 후보는 59%의 "Kyle Diamantas"이며, 마켓이 해당 결과에 59%의 확률을 부여합니다. 두 번째로 가까운 결과는 49%의 "Sara Brenner"입니다. 이 확률은 트레이더들의 주식 매수 및 매도에 따라 실시간으로 업데이트되어 가장 가능성 있는 결과에 대한 최신 집단 시각을 반영합니다. 새로운 정보가 나타남에 따라 확률이 어떻게 변화하는지 자주 확인하거나 이 페이지를 북마크하세요.

"트럼프는 다음 FDA 위원으로 누구를 발표할 것인가?"의 정산 규칙은 각 결과가 승자로 선언되기 위해 정확히 무엇이 일어나야 하는지를 정의합니다 — 결과를 결정하는 데 사용되는 공식 데이터 소스를 포함합니다. 이 페이지의 댓글 위 "규칙" 섹션에서 완전한 정산 기준을 검토할 수 있습니다. 거래 전 규칙을 주의 깊게 읽는 것을 권장합니다. 이 마켓이 어떻게 정산되는지를 관리하는 정확한 조건, 예외 사항, 출처를 명시하고 있습니다.